Source:http://linkedlifedata.com/resource/pubmed/id/19588396
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2009-7-9
|
| pubmed:abstractText |
Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs are frequently used as first-line treatment in primary and secondary care settings. Milnacipran, a dual serotonin-norepinephrine reuptake inhibitor (SNRI), is one of the antidepressant drugs that clinicians use for routine depression care.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1469-493X
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
CD006529
|
| pubmed:meshHeading |
pubmed-meshheading:19588396-Antidepressive Agents,
pubmed-meshheading:19588396-Cyclopropanes,
pubmed-meshheading:19588396-Depressive Disorder, Major,
pubmed-meshheading:19588396-Humans,
pubmed-meshheading:19588396-Randomized Controlled Trials as Topic,
pubmed-meshheading:19588396-Serotonin Uptake Inhibitors
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Milnacipran versus other antidepressive agents for depression.
|
| pubmed:affiliation |
Department of Psychiatry, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, Japan, 160-8582.
|
| pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|